Evidence map›Paper›PMID 28481933›Full record

ArticlePloS one2017

The limits to growth - energetic burden of the endogenous antibiotic tropodithietic acid in Phaeobacter inhibens DSM 17395.

Sabine Eva Will, Meina Neumann-Schaal, Raymond Leopold Heydorn, Pascal Bartling, Jörn Petersen, Dietmar Schomburg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification and Biosynthesis of Tropodithietic Acid byInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Thiol Metabolism and Volatile Metabolome ofFrontiers in microbiology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The planctomycete Stieleria maiorica Mal15Communications biology · 2020
    Article
  16. Article
  17. Causes and Consequences of a Variant Strain ofFrontiers in microbiology · 2018
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sabine Eva WillTechnische Universität Braunschweig, Department of Bioinformatics and Biochemistry and Braunschweig Integrated Center of Systems Biology (BRICS), Braunschweig, Germany.
Meina Neumann-SchaalTechnische Universität Braunschweig, Department of Bioinformatics and Biochemistry and Braunschweig Integrated Center of Systems Biology (BRICS), Braunschweig, Germany.
Raymond Leopold HeydornTechnische Universität Braunschweig, Department of Bioinformatics and Biochemistry and Braunschweig Integrated Center of Systems Biology (BRICS), Braunschweig, Germany.
Pascal BartlingLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Jörn PetersenLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Dietmar SchomburgTechnische Universität Braunschweig, Department of Bioinformatics and Biochemistry and Braunschweig Integrated Center of Systems Biology (BRICS), Braunschweig, Germany.ORCID http://orcid.org/0000-0002-3354-822X
Technische Universität Braunschweig · DELeibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phaeobacter inhibens DSM 17395, a model organism for marine Roseobacter group, was studied for its response to its own antimicrobial compound tropodithietic acid (TDA). TDA biosynthesis is encoded on the largest extrachromosomal element of P. inhibens, the 262 kb plasmid, whose curation leads to an increased growth and biomass yield. In this study, the plasmid-cured strain was compared to the wild-type strain and to transposon mutants lacking single genes of the TDA biosynthesis. The data show that the growth inhibition of the wild-type strain can be mainly attributed to the TDA produced by P. inhibens itself. Oxygen uptake rates remained constant in all strains but the growth rate dropped in the wild-type which supports the recently proposed mode of TDA action. Metabolome analysis showed no metabolic alterations that could be attributed directly to TDA. Taken together, the growth of P. inhibens is limited by its own antibacterial compound due to a partial destruction of the proton gradient which leads to a higher energetic demand. The universal presence of TDA biosynthesis in genome-sequenced isolates of the genus Phaeobacter shows that there must be a high benefit of TDA for P. inhibens in its ecological niche despite the drawback on its metabolism.

Indexed as

Anti-Bacterial AgentsMetabolomeMutationOxygenRhodobacteraceaeTropoloneAnti-Bacterial AgentsOxygentropodithietic acidTropolone

Identifiers

PMID28481933
PMCPMC5421792
OpenAlexW2612992155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.